Variant report
Variant | nsv975448 |
---|---|
Chromosome Location | chr12:10587805-10600415 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:202)
- CpG islands (count:122)
- Chromatin interactive region (count:1)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr12:10592356-10592503 | HepG2 | liver: | n/a | n/a |
2 | BATF | chr12:10598779-10599011 | GM12878 | blood: | n/a | chr12:10598893-10598904 |
3 | BCL11A | chr12:10598783-10598965 | GM12878 | blood: | n/a | n/a |
4 | BCL3 | chr12:10592167-10592607 | A549 | lung: | n/a | n/a |
5 | CEBPB | chr12:10590386-10590401 | HepG2 | liver: | n/a | n/a |
6 | CEBPB | chr12:10600201-10600212 | A549 | lung: | n/a | n/a |
7 | CEBPB | chr12:10592348-10592508 | HepG2 | liver: | n/a | n/a |
8 | CEBPB | chr12:10592194-10592559 | A549 | lung: | n/a | n/a |
9 | CEBPB | chr12:10588520-10588745 | Hela-S3 | cervix: | n/a | n/a |
10 | CEBPB | chr12:10590272-10590510 | K562 | blood: | n/a | n/a |
11 | CEBPB | chr12:10592190-10592807 | Hela-S3 | cervix: | n/a | n/a |
12 | CEBPB | chr12:10590205-10590581 | Hela-S3 | cervix: | n/a | n/a |
13 | CHD2 | chr12:10590372-10590413 | Hela-S3 | cervix: | n/a | n/a |
14 | CTCF | chr12:10593080-10593174 | MCF-7 | breast: | n/a | n/a |
15 | CTCF | chr12:10593047-10593172 | Fibrobl | skin: | n/a | n/a |
16 | CTCF | chr12:10593072-10593203 | GM19239 | blood: | n/a | n/a |
17 | CTCF | chr12:10600167-10600223 | LNCaP | prostate: | n/a | n/a |
18 | CTCF | chr12:10593082-10593151 | MCF-7 | breast: | n/a | n/a |
19 | CTCF | chr12:10591453-10591491 | A549 | lung: | n/a | n/a |
20 | CTCF | chr12:10593095-10593127 | MCF-7 | breast: | n/a | n/a |
21 | CTCF | chr12:10593058-10593183 | A549 | lung: | n/a | n/a |
22 | CTCF | chr12:10593076-10593192 | Hela-S3 | cervix: | n/a | n/a |
23 | CTCF | chr12:10592724-10592809 | Hela-S3 | cervix: | n/a | n/a |
24 | CTCF | chr12:10593084-10593189 | Gliobla | brain: | n/a | n/a |
25 | CTCF | chr12:10593932-10594014 | A549 | lung: | n/a | n/a |
26 | CTCF | chr12:10593138-10593151 | NHEK | skin: | n/a | n/a |
27 | CTCF | chr12:10597587-10597650 | Fibrobl | skin: | n/a | n/a |
28 | ELK1 | chr12:10588527-10588719 | Hela-S3 | cervix: | n/a | n/a |
29 | EP300 | chr12:10592182-10592673 | A549 | lung: | n/a | n/a |
30 | EP300 | chr12:10592256-10592466 | HepG2 | liver: | n/a | n/a |
31 | EP300 | chr12:10592290-10592548 | Hela-S3 | cervix: | n/a | n/a |
32 | EP300 | chr12:10588524-10588752 | Hela-S3 | cervix: | n/a | chr12:10588711-10588721 |
33 | EP300 | chr12:10590365-10590566 | Hela-S3 | cervix: | n/a | chr12:10590546-10590553 chr12:10590462-10590471 |
34 | EP300 | chr12:10592166-10592799 | A549 | lung: | n/a | n/a |
35 | ESR1 | chr12:10590207-10590434 | T-47D | breast: | n/a | chr12:10590337-10590352 |
36 | ESR1 | chr12:10590231-10590567 | T-47D | breast: | n/a | chr12:10590337-10590352 |
37 | FAM48A | chr12:10588552-10588758 | Hela-S3 | cervix: | n/a | n/a |
38 | FOS | chr12:10590370-10590571 | MCF10A-Er-Src | breast: | n/a | n/a |
39 | FOS | chr12:10598897-10598980 | MCF10A-Er-Src | breast: | n/a | n/a |
40 | FOS | chr12:10588540-10588758 | MCF10A-Er-Src | breast: | n/a | n/a |
41 | FOS | chr12:10592282-10592865 | MCF10A-Er-Src | breast: | n/a | n/a |
42 | FOS | chr12:10592443-10592862 | MCF10A-Er-Src | breast: | n/a | n/a |
43 | FOS | chr12:10588533-10588731 | MCF10A-Er-Src | breast: | n/a | n/a |
44 | FOS | chr12:10598795-10598956 | MCF10A-Er-Src | breast: | n/a | n/a |
45 | FOS | chr12:10598962-10598968 | MCF10A-Er-Src | breast: | n/a | n/a |
46 | FOS | chr12:10590373-10590564 | MCF10A-Er-Src | breast: | n/a | n/a |
47 | FOS | chr12:10592628-10592864 | MCF10A-Er-Src | breast: | n/a | n/a |
48 | FOS | chr12:10592306-10592864 | MCF10A-Er-Src | breast: | n/a | n/a |
49 | FOS | chr12:10588532-10588763 | MCF10A-Er-Src | breast: | n/a | n/a |
50 | FOS | chr12:10598884-10598999 | MCF10A-Er-Src | breast: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr12:10599740-10599790 | HCT-116 | colon: | n/a |
2 | chr12:10588483-10588533 | ECC-1 | luminal epithelium: | n/a |
3 | chr12:10588483-10588533 | RPTEC | kidney: | n/a |
4 | chr12:10588483-10588533 | AG09309 | skin: | n/a |
5 | chr12:10588483-10588533 | GM12891 | blood: | n/a |
6 | chr12:10599740-10599790 | HRCEpiC | kidney: | n/a |
7 | chr12:10588483-10588533 | HRPEpiC | eye: | n/a |
8 | chr12:10599740-10599790 | HepG2 | liver: | n/a |
9 | chr12:10599740-10599790 | HPAEpiC | pulmonary alveolar: | n/a |
10 | chr12:10588483-10588533 | HepG2 | liver: | n/a |
11 | chr12:10588483-10588533 | BE2_C | brain: | n/a |
12 | chr12:10599740-10599790 | LNCaP | prostate: | n/a |
13 | chr12:10599740-10599790 | SK-N-SH_RA | brain: | n/a |
14 | chr12:10599740-10599790 | A549 | lung: | n/a |
15 | chr12:10588483-10588533 | GM12892 | blood: | n/a |
16 | chr12:10599740-10599790 | ECC-1 | luminal epithelium: | n/a |
17 | chr12:10588483-10588533 | Hela-S3 | cervix: | n/a |
18 | chr12:10599740-10599790 | CMK | blood: | n/a |
19 | chr12:10588483-10588533 | HRCEpiC | kidney: | n/a |
20 | chr12:10599740-10599790 | HCPEpiC | choroid plexus: | n/a |
21 | chr12:10599740-10599790 | HNPCEpiC | eye: | n/a |
22 | chr12:10588483-10588533 | HCPEpiC | choroid plexus: | n/a |
23 | chr12:10588483-10588533 | Caco-2 | colon: | n/a |
24 | chr12:10599740-10599790 | NHDF-neo | bronchial: | n/a |
25 | chr12:10599740-10599790 | BE2_C | brain: | n/a |
26 | chr12:10599740-10599790 | NH-A | brain: | n/a |
27 | chr12:10588483-10588533 | H1-hESC | embryonic stem cell: | embryo |
28 | chr12:10588483-10588533 | NT2-D1 | testis: | n/a |
29 | chr12:10599740-10599790 | RPTEC | kidney: | n/a |
30 | chr12:10599740-10599790 | GM12891 | blood: | n/a |
31 | chr12:10599740-10599790 | H1-hESC | embryonic stem cell: | embryo |
32 | chr12:10599740-10599790 | GM19239 | blood: | n/a |
33 | chr12:10599740-10599790 | HEEpiC | esophagus: | n/a |
34 | chr12:10588483-10588533 | PANC-1 | pancreas: | n/a |
35 | chr12:10599740-10599790 | K562 | blood: | n/a |
36 | chr12:10599740-10599790 | HRPEpiC | eye: | n/a |
37 | chr12:10599740-10599790 | AG09309 | skin: | n/a |
38 | chr12:10588483-10588533 | HRE | kidney: | n/a |
39 | chr12:10588483-10588533 | HPAEpiC | pulmonary alveolar: | n/a |
40 | chr12:10599740-10599790 | IMR90 | lung: | fetal |
41 | chr12:10588483-10588533 | HMEC | breast: | n/a |
42 | chr12:10588483-10588533 | AoSMC | blood vessel: | n/a |
43 | chr12:10588483-10588533 | T-47D | breast: | n/a |
44 | chr12:10599740-10599790 | HMEC | breast: | n/a |
45 | chr12:10599740-10599790 | HAEpiC | amniotic membrane: | n/a |
46 | chr12:10599740-10599790 | HRE | kidney: | n/a |
47 | chr12:10599740-10599790 | AG09319 | gingival: | n/a |
48 | chr12:10599740-10599790 | PANC-1 | pancreas: | n/a |
49 | chr12:10588483-10588533 | NHBE | bronchial: | n/a |
50 | chr12:10588483-10588533 | SK-N-SH_RA | brain: | n/a |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr12:10572017..10574193-chr12:10588542..10590731,2 | MCF-7 | breast: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-EIF2S3L.1-6 | chr12:10597246-10597382 | l_610_chr12:10597245-10602083_whiteBloodCell |
No data |
No data |
Variant related genes | Relation type |
---|---|
KLRC2 | TF binding region |
ENSG00000255641 | TF binding region |
KLRC2 | CpG island |
ENSG00000255641 | CpG island |
ENSG00000205810 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs551083640 | chr12:10587816-10587817 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs565040481 | chr12:10587861-10587862 | Active TSS Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs527356906 | chr12:10587878-10587879 | Active TSS Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs547246830 | chr12:10587883-10587884 | Active TSS Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs567083366 | chr12:10587887-10587888 | Active TSS Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs376307266 | chr12:10587889-10587890 | Active TSS Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs200938482 | chr12:10587942-10587943 | Active TSS Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs536027875 | chr12:10587952-10587953 | Active TSS Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs148303942 | chr12:10587954-10587955 | Active TSS Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs368882379 | chr12:10588012-10588013 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs549652679 | chr12:10588026-10588027 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs569409556 | chr12:10588044-10588045 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs538278508 | chr12:10588046-10588047 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs557864610 | chr12:10588048-10588049 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs577749927 | chr12:10588052-10588053 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs558485778 | chr12:10588081-10588082 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs111680143 | chr12:10588102-10588103 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs553822667 | chr12:10588168-10588169 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs573504609 | chr12:10588176-10588177 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs34564759 | chr12:10588196-10588197 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs149427466 | chr12:10588222-10588223 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs542375243 | chr12:10588223-10588224 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs562844385 | chr12:10588240-10588241 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs111521889 | chr12:10588286-10588287 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs113029910 | chr12:10588297-10588298 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs545019771 | chr12:10588310-10588311 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs113784967 | chr12:10588312-10588313 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs147526459 | chr12:10588331-10588332 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs544155214 | chr12:10588344-10588345 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs377697161 | chr12:10588353-10588354 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs372993468 | chr12:10588362-10588363 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs371517651 | chr12:10588367-10588368 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs376535440 | chr12:10588373-10588374 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs374205074 | chr12:10588383-10588384 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs529518672 | chr12:10588414-10588415 | Enhancers Active TSS Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs113695732 | chr12:10588418-10588419 | Enhancers Active TSS Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs147031208 | chr12:10588420-10588421 | Enhancers Active TSS Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs538141639 | chr12:10588422-10588423 | Enhancers Active TSS Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs138243943 | chr12:10588424-10588425 | Enhancers Active TSS Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs112954418 | chr12:10588439-10588440 | Enhancers Active TSS Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs111237999 | chr12:10588444-10588445 | Enhancers Active TSS Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs143724007 | chr12:10588451-10588452 | Enhancers Active TSS Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs111449827 | chr12:10588454-10588455 | Enhancers Active TSS Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs574094142 | chr12:10588455-10588456 | Enhancers Active TSS Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs369621419 | chr12:10588475-10588476 | Enhancers Active TSS Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs371980904 | chr12:10588484-10588485 | Enhancers Active TSS Bivalent Enhancer | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs150565275 | chr12:10588518-10588519 | Enhancers Active TSS Bivalent Enhancer | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs75545535 | chr12:10588530-10588531 | Enhancers Active TSS Bivalent Enhancer | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs201399315 | chr12:10588531-10588532 | Enhancers Active TSS Bivalent Enhancer | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs7956272 | chr12:10588565-10588566 | Enhancers Active TSS Bivalent Enhancer | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 17690704 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Breast cancer | 22032731 | CNVD |
Cancer | 21183584 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 21965145 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Prostate cancer | 19156837 | CNVD |
Emphysema | 19352772 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Malignant germ cell tumour | 17285132 | CNVD |
Melanoma | 18172304 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Breast cancer | 21264507 | CNVD |
Cancer | 16751803 | CNVD |
Testicular cancer | 18059402 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Seminomas | 18059402 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21858162 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21611746 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Squamous cell cancer | 19607727 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Acute myeloid leukemia | 17268525 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Prostate cancer | 16461572 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:10584200-10588000 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
2 | chr12:10585800-10589000 | Active TSS | Primary Natural Killer cells fromperipheralblood | blood |
3 | chr12:10587000-10588000 | Weak transcription | Hela-S3 | cervix |
4 | chr12:10588000-10588400 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
5 | chr12:10588000-10588600 | Active TSS | Fetal Thymus | thymus |
6 | chr12:10588000-10588800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
7 | chr12:10588000-10588800 | Active TSS | Brain Anterior Caudate | brain |
8 | chr12:10588000-10588800 | Active TSS | Hela-S3 | cervix |
9 | chr12:10588200-10588800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
10 | chr12:10588200-10588800 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
11 | chr12:10588200-10589000 | Enhancers | Muscle Satellite Cultured Cells | -- |
12 | chr12:10588200-10589000 | Enhancers | A549 | lung |
13 | chr12:10588200-10589000 | Enhancers | HUVEC | blood vessel |
14 | chr12:10588400-10588800 | Bivalent Enhancer | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
15 | chr12:10588800-10589400 | Enhancers | Hela-S3 | cervix |
16 | chr12:10588800-10592600 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
17 | chr12:10589000-10590600 | Weak transcription | A549 | lung |
18 | chr12:10589000-10591200 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
19 | chr12:10589400-10593800 | Weak transcription | Hela-S3 | cervix |
20 | chr12:10590600-10591200 | Enhancers | A549 | lung |
21 | chr12:10590600-10591200 | Enhancers | NHEK | skin |
22 | chr12:10591200-10591600 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
23 | chr12:10591600-10597600 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
24 | chr12:10593800-10594000 | Enhancers | Hela-S3 | cervix |
25 | chr12:10597600-10598000 | Genic enhancers | Primary Natural Killer cells fromperipheralblood | blood |
26 | chr12:10598000-10600800 | Strong transcription | Primary Natural Killer cells fromperipheralblood | blood |
27 | chr12:10598600-10599800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |